CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Sep 22, 2022. (Total: 4021 publications since 2011)

All HLBS RCH FHH Equity Diabetes Rare Cancer COVID-19 ND PGx PI Environmental dataset

Filtered By: Select to fine-tune your search CDC Author Year CDC Organization Journal

Records 1-10 (of 10 Records)

Query Trace: all>>Priya Ranjan[CDC Author]
PAMPer and tRIGer: ligand-induced activation of RIG-I. J Bradford Bowzard, William G Davis, Victoria Jeisy-Scott, Priya Ranjan, Shivaprakash Gangappa, Takashi Fujita, and Suryaprakash Sambhara Trends in biochemical sciences 2011 Jun 36(6) 314-9 Similar articles in PubMed DOI:10.1016/j.tibs.2011.03.003
Influenza virus NS1- C/EBPβ gene regulatory complex inhibits RIG-I transcription. Rashmi Kumari, Zhu Guo, Amrita Kumar, Mayim Wiens, Shivaprakash Gangappa, Jacqueline M Katz, Nancy J Cox, Renu B Lal, Devanand Sarkar, Paul B Fisher, Adolfo García-Sastre, Takashi Fujita, Vijay Kumar, Suryaprakash Sambhara, Priya Ranjan, and Sunil K Lal Antiviral research 2020 Feb 104747 Similar articles in PubMed DOI:10.1016/j.antiviral.2020.104747
Critical role of RIG-I and MDA5 in early and late stages of Tulane virus infection. Preeti Chhabra, Priya Ranjan, Theresa Cromeans, Suryaprakash Sambhara, and Jan Vinjé The Journal of general virology 2017 May 98(5) 1016-1026 Similar articles in PubMed DOI:10.1099/jgv.0.000769
Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Amrita Kumar, Jin Hyang Kim, Priya Ranjan, Maureen G Metcalfe, Weiping Cao, Margarita Mishina, Shivaprakash Gangappa, Zhu Guo, Edward S Boyden, Sherif Zaki, Ian York, Adolfo García-Sastre, Michael Shaw, and Suryaprakash Sambhara Scientific reports 2017 Jan 740360 Similar articles in PubMed DOI:10.1038/srep40360
NLRC5 interacts with RIG-I to induce a robust antiviral response against influenza virus infection. Priya Ranjan, Neetu Singh, Amrita Kumar, Andreas Neerincx, Elisabeth Kremmer, Weiping Cao, William G Davis, Jacqueline M Katz, Shivaprakash Gangappa, Rongtuan Lin, Thomas A Kufer, and Suryaprakash Sambhara Eur. J. Immunol. 2015 Mar 45(3) 758-72 Similar articles in PubMed DOI:10.1002/eji.201344412
Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. Raveendra R Kulkarni, Mohammed Ata Ur Rasheed, Siddhartha Kumar Bhaumik, Priya Ranjan, Weiping Cao, Carl Davis, Krishna Marisetti, Sunil Thomas, Shivaprakash Gangappa, Suryaprakash Sambhara, and Kaja Murali-Krishna J. Virol. 2014 Dec 88(24) 13990-4001 Similar articles in PubMed DOI:10.1128/JVI.02273-14
RIG-I goes beyond naked recognition. J Bradford Bowzard, Priya Ranjan, and Suryaprakash Sambhara Cell Host Microbe 2013 Mar 13. 13(3) 247-9 Similar articles in PubMed DOI:10.1016/j.chom.2013.02.012
The 3' untranslated regions of influenza genomic sequences are 5'PPP-independent ligands for RIG-I. William G Davis, J Bradford Bowzard, Suresh D Sharma, Mayim E Wiens, Priya Ranjan, Shivaprakash Gangappa, Olga Stuchlik, Jan Pohl, Ruben O Donis, Jacqueline M Katz, Craig E Cameron, Takashi Fujita, and Suryaprakash Sambhara PLoS ONE 2012 7(3) e32661 Similar articles in PubMed DOI:10.1371/journal.pone.0032661
Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. Kulbhushan Sharma, Shashank Tripathi, Priya Ranjan, Purnima Kumar, Rebecca Garten, Varough Deyde, Jacqueline M Katz, Nancy J Cox, Renu B Lal, Suryaprakash Sambhara, and Sunil K Lal PLoS ONE 2011 6(6) e20215 Similar articles in PubMed DOI:10.1371/journal.pone.0020215
NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-?B signaling pathways. Irving C Allen, Chris B Moore, Monika Schneider, Yu Lei, Beckley K Davis, Margaret A Scull, Denis Gris, Kelly E Roney, Albert G Zimmermann, John B Bowzard, Priya Ranjan, Kathryn M Monroe, Raymond J Pickles, Suryaprakash Sambhara, and Jenny P Y Ting Immunity 2011 Jun 24. 34(6) 854-65 Similar articles in PubMed DOI:10.1016/j.immuni.2011.03.026